DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Pipamperone is an investigational drug.
There have been 4 clinical trials for Pipamperone. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2011.
The most common disease conditions in clinical trials are Schizophrenia, Disease, and Depressive Disorder, Major. The leading clinical trial sponsors are PharmaNeuroBoost N.V., Hannover Medical School, and [disabled in preview].
There are two US patents protecting this investigational drug and seventeen international patents.
Recent Clinical Trials for Pipamperone
|Pharmacovigilance in Gerontopsychiatric Patients||Hannover Medical School||Phase 3|
|POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia||PharmaNeuroBoost N.V.||Phase 2|
|Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)||PharmaNeuroBoost N.V.||Phase 3|
Top disease conditions for Pipamperone
Top clinical trial sponsors for Pipamperone
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Pipamperone||Get Started Free||Quinolone-based compounds, formulations, and uses thereof||University of South Florida (Tampa, FL) Northeastern University (Boston, MA)||Get Started Free|
|Pipamperone||Get Started Free||Substituted 4,5,6,7-tetrahydropyrazolo[3,4-c]pyridines as factor XIa inhibitors||Bristol-Myers Squibb Company (Princeton, NJ)||Get Started Free|
|Pipamperone||Get Started Free||Compositions and methods for treating Dengue virus infection||The J. David Gladstone Institutes (San Francisco, CA) The Regents of the University of California (Oakland, CA)||Get Started Free|
|Pipamperone||Get Started Free||Compounds useful for the treatment of metabolic disorders and synthesis of the same||North Carolina Central University (Durham, NC) The University of North Carolina at Chapel Hill (Chapel Hill, NC)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Pipamperone||China||CN103987697||2031-10-14||Get Started Free|
|Pipamperone||European Patent Office||EP2766345||2031-10-14||Get Started Free|
|Pipamperone||European Patent Office||EP2899183||2031-10-14||Get Started Free|
|Pipamperone||Spain||ES2572908||2031-10-14||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|